PALATIN TECHNOLOGIES, INC. Foreign Currency Transaction Gain (Loss), before Tax
PALATIN TECHNOLOGIES, INC. (PTN) reported Foreign Currency Transaction Gain (Loss), before Tax of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was $15.85K.
- PALATIN TECHNOLOGIES, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-03-31 was -$27.90K, a 112.94% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2024-12-31 was $143.60K.
- PALATIN TECHNOLOGIES, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$50.00, a 100.08% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was $59.75K.
- PALATIN TECHNOLOGIES, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$429.97K, a 210.29% decline from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was $389.87K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $15.85K derived: sum of 2 quarters · filed 2025-11-14 | -$12.05K derived: sum of 3 quarters · filed 2026-05-13 | $131.55K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | $15.85K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$12.05K derived: sum of 2 quarters · filed 2026-05-13 | $131.55K derived: sum of 3 quarters · filed 2026-05-13 | -$50.00 10-K · filed 2025-09-23 |
| 2025-03-31 | -$27.90K 10-Q · filed 2026-05-13 | $115.70K derived: sum of 2 quarters · filed 2026-05-13 | -$15.90K 10-Q · filed 2026-05-13 | -$24.80K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $143.60K 10-Q · filed 2026-02-17 | $12.00K 10-Q · filed 2026-02-17 | $3.10K derived: sum of 3 quarters · filed 2026-02-17 | $218.70K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | -$131.60K 10-Q · filed 2025-11-14 | -$140.50K derived: sum of 2 quarters · filed 2025-11-14 | $75.10K derived: sum of 3 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$8.90K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $206.70K derived: sum of 2 quarters · filed 2025-09-23 | $59.75K 10-K · filed 2025-09-23 | |
| 2024-03-31 | $215.60K 10-Q · filed 2025-05-14 | $68.65K 10-Q · filed 2025-05-14 | ||
| 2023-06-30 | -$429.97K 10-K · filed 2023-09-28 | |||
| 2022-12-31 | -$693.23K 10-Q · filed 2023-02-14 | -$274.86K 10-Q · filed 2023-02-14 | ||
| 2022-09-30 | $418.38K 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $389.87K 10-K · filed 2023-09-28 | |||
| 2021-12-31 | -$234.08K 10-Q · filed 2023-02-14 | -$126.72K 10-Q · filed 2023-02-14 | -$347.99K derived: sum of 3 quarters · filed 2023-02-14 | $405.76K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $107.36K 10-Q · filed 2022-11-14 | -$113.92K derived: sum of 2 quarters · filed 2022-11-14 | $639.84K derived: sum of 3 quarters · filed 2022-11-14 | -$105.17K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$221.27K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $532.48K derived: sum of 2 quarters · filed 2022-09-22 | -$212.53K derived: sum of 3 quarters · filed 2022-09-22 | -$212.53K 10-K · filed 2022-09-22 |
| 2021-03-31 | $753.75K 10-Q · filed 2021-05-14 | $8.75K derived: sum of 2 quarters · filed 2022-02-14 | $8.75K 10-Q · filed 2021-05-14 | $8.75K derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-12-31 | -$745.00K 10-Q · filed 2022-02-14 | -$745.00K 10-Q · filed 2022-02-14 | -$745.00K derived: sum of 3 quarters · filed 2022-02-14 | -$745.00K derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 derived: sum of 3 quarters · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $0.00 derived: sum of 2 quarters · filed 2021-09-28 | $0.00 derived: sum of 3 quarters · filed 2021-09-28 | $0.00 10-K · filed 2021-09-28 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |